Establishment of an Induced Pluripotent Stem Cell Line from a Patient with CHARGE Syndrome Carrying a CHD7 (p.l1151gfs*17) Mutation

Shouhuan He,Jintao Hu,Zhong Zheng,Jingjing Wang,Jianling Chen,Cui Zhang,Liang Li,Jiping Wang,Zhengnong Chen,Haibo Shi,Jinfu Wang

DOI: https://doi.org/10.1016/j.scr.2020.101774

IF: 1.587

2020-01-01

Stem Cell Research

Abstract:CHARGE syndrome is a rare disease caused by a genetic disorder. The clinical features of this syndrome include coloboma of the eye, heart anomaly, choanal atresia, retardation of mental and somatic development, microphallus, ear abnormalities and/or deafness. CHD7 is the main causative gene for CHARGE syndrome. In this study, we generated an induced pluripotent stem cell (iPSC) line from the dermal fibroblasts of a 1.5-year-old girl, carrying a de novo mutation (CHD7;NM_017780;c.3449_3450delTC;p.L1151Gfs*17). This iPSC line will be a useful tool for investigating the pathogenesis and for developing treatment for this complicated syndrome.